CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −123 | $598.84 | $74K | 330,863 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −800 | $599.93 | $480K | 330,063 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $600.97 | $361K | 329,463 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $602.04 | $193K | 329,143 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $603.53 | $97K | 328,983 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $604.46 | $48K | 328,903 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $605.74 | $24K | 328,863 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −529 | $607.35 | $321K | 328,334 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −923 | $608.30 | $561K | 327,411 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,245 | $609.09 | $758K | 326,166 |
| 2026-11-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 90,910 | ||
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −426 | $598.68 | $255K | 333,517 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,284 | $599.80 | $770K | 332,233 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,202 | $600.73 | $1.3M | 330,031 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,440 | $601.54 | $866K | 328,591 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,261 | $602.79 | $760K | 327,330 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,927 | $603.70 | $1.2M | 325,403 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −840 | $604.65 | $508K | 324,563 |
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $605.97 | $73K | 324,443 |
Page 8 of 64 · 1,267 trades